Central Trust Company’s AvePoint AVPT Stock Holding History

Central Trust Company’s Portfolio AVPT Stock Details AVPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,600	Closed	-$29K	–	1185
2021 Q1	$29K	Buy	2,600 +100	+4%	+$1.4K	﹤0.01%	768
2020 Q4	$38K	Buy	+2,500	New	+$29.9K	﹤0.01%	726

Other funds holding AVPT

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MAC

Monarch Alternative Capital New York $707M AUM 177.52% 1-Year Est. Return

BPIM

Brant Point Investment Management New York $813M AUM 60.46% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Central Trust Company's AVPT Position: Q2 2021 in Review

Central Trust Company sold out of AvePoint (AVPT) in Q2 2021, closing a stake of 2,600 shares — an estimated $29K sold.

Central Trust Company first reported a position in AVPT in Q4 2020 and held it in 2 quarters. The position peaked at $38K in Q4 2020. 33 funds tracked by Wall St. Rank hold AVPT as of Q2 2021.

Central Trust Company reported no remaining AvePoint position as of Q2 2021 after selling out during the quarter.
Central Trust Company sold 2,600 AvePoint shares in Q2 2021, an estimated $29K.
Central Trust Company first reported a position in AvePoint in Q4 2020 and held it in 2 quarters.
Central Trust Company's AvePoint position peaked at $38K in Q4 2020.
33 funds tracked by Wall St. Rank held AvePoint as of Q2 2021.

Based on Central Trust Company's 13F filing for Q2 2021, filed 23 Jul 2021.